Trials / Completed
CompletedNCT05476588
Tobacco, Alcohol, Prescription Drug, and Illicit Substance Use- Electronic Spanish Platform
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,000 (actual)
- Sponsor
- Baylor Research Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The goal of this study is to validate the TAPS-ESP as a screen and assessment that can be used in primary care for the screening and treatment of substance use.
Detailed description
This Phase II study seeks to conduct further research to validate the TAPS-ESP as a Spanish language version of the screening and brief assessment and pave the way for its broad dissemination in the healthcare system. The investigators will use a novel application of a Type 1 hybrid effectiveness-implementation design, adapted to a screening validation study. The investigators will conduct a large-scale study to validate the TAPS-ESP against established diagnostic and biomarker metrics, replicating the design of the seminal English-language TAPS study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Screening | Screening and validation of assessment tool translated into Spanish |
Timeline
- Start date
- 2022-07-15
- Primary completion
- 2024-03-14
- Completion
- 2024-03-14
- First posted
- 2022-07-27
- Last updated
- 2026-01-26
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05476588. Inclusion in this directory is not an endorsement.